At the recent Innovation Day seminar hosted by Complementary Medicines Australia (CMA), Gnosis by Lesaffre, led by Jose Pinedo Rivera, Product Manager, had the opportunity to present MyCondro™ to an engaged audience of over 250 industry professionals. The session, “Keeping Pace with a Changing World: MyCondro™ Disrupts the Chondroitin Sulfate Market,” was well received, sparking interest and conversations around the future of joint health solutions.
Addressing Industry Challenges With Proven Science
MyCondro™ stood out as a breakthrough solution addressing the limitations of animal-based chondroitin, including supply chain variability, risk of contamination, and ethical concerns. Through the presentation, Gnosis highlighted how this fermentation-derived ingredient delivers 45% higher bioavailability, proven clinical efficacy at a lower dosage, and consistent purity that surpasses regulatory standards. As the world shifts toward cleaner, more responsible nutraceuticals, MyCondro™ emerged as a compelling option for brands looking to innovate and meet consumer expectations.
Engaging One-to-One: Bringing Innovation Closer
In addition to the presentation, The Gnosis booth at the CMA event allowed connection with attendees in more personal, one-to-one discussions. These interactions offered a valuable platform to explain further why MyCondro™ matters—its scientific foundation, production innovation, and potential for expanded applications in areas like metabolic health and inflammation management. Overall, the seminar was a successful moment to communicate not just what Gnosis offers, but why and how the company is leading the transformation of the joint health category.
Furthermore, the structure of MyCondro™ closely resembles human synovial fluid, which may contribute to its efficacy in promoting joint health. Its low molecular weight and homogeneous composition enhance its bioactivity, making it a promising option for individuals seeking to maintain joint function and mobility.
Discover MyCondro™
Chondroitin sulfate has been traditionally sourced from animals, but concerns over cross-contamination and manufacturing processes, as driven demand for a non-animal source of this key nutrient. Gnosis by Lesaffre is proud to fulfill this demand with its revolutionary ingredient MyCondro™.
